Plasma cell dyscrasia affects up to 5% of adults. While often asymptomatic, its characteristic clonal expansion of bone marrow plasma cells can also indicate the presence of several hematological malignancies including multiple myeloma.
GLP-1 Use Reduces Risk of MGUS Progression in Some Veterans
Glucagon-like peptide 1 (GLP-1) receptor agonists have gained huge popularity as they have demonstrated the ability to substantially reduce both blood-glucose levels and weight. In addition, recent research suggests cardiovascular and renal benefits to their use in certain populations.
VA Will Assess Leukemias, Multiple Myeloma as Presumptive Service Conditions
In what could be the first conditions added to the new PACT Act, the VA is conducting a scientific review to determine any relationship between three conditions—acute leukemias, chronic leukemias, and multiple myeloma outside of the head and neck—and toxic exposures for servicemembers who deployed to Iraq, Afghanistan, Somalia, Djibouti, Egypt, Jordan, Lebanon, Syria, Yemen, Uzbekistan, and the entire Southwest Asia theater of operations.
Multiple Myeloma Unusual in Younger Patients, Behaves Differently
Multiple myeloma (MM) is extremely unusual in adolescents and young adults (AYAs) younger than 45, and, when it does occur, often has some unusual features.
Obesity/Weight Gain Associated with MGUS Progression to Multiple Myeloma
Obesity ranks high in the list of risk factors for the development of monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM).
MGUS-MM Progression Differs Between African Americans, Caucasians
While it is widely known that African Americans (AA) are at higher risk for multiple myeloma (MM), precisely what factors create the disparity are not well understood.
Is It Time to Rethink Stem Cell Transplantation in Young Patients With MM?
BETHESDA, MD—Multiple myeloma (MM) is primarily a disease of the elderly, with an average age at diagnosis of 68. Still, adolescents and young adults (AYAs) do develop the blood disease and represent about 5% of all new cases. Because MM is so uncommon in younger age...
COVID-19 Minimally Affected Prescriptions, Hospital Admissions for Veterans with MM
As COVID-19 burst upon the world stage, medical care rapidly shifted from in-person visits to telemedicine consultations with varying results among patients with chronic conditions, cancer and other diseases that required regular and ongoing interaction with medical personnel.
Surprise! Some Secondary Primary Malignancies in MM Linked to Longer Overall Survival
For 70 years, physicians and researchers have been aware of secondary primary malignancies (SPM) in patients with multiple myeloma.
Multiple Myeloma Patients Usually Respond Well to COVID-19 Vaccines
While about one-fourth of blood cancer patients failed to produce detectable antibodies after COVID-19 vaccination, those with multiple myeloma fared better than most.
Genetic 17p Deletion Doesn’t Affect MM Survival by Race
African Americans have an increased incidence of multiple myeloma (MM) but do not appear to be at a disadvantage in terms of overall survival, however.
Hormones Affect Sexual Function After AHSCT
How do hormones affect sexual function recovery after autologous hematopoietic stem cell transplantation (AHSCT), which is the standard of care for younger patients with newly diagnosed multiple myeloma.